Phase I/IB trial of eribulin and everolimus in patients with triple-negative metastatic breast cancer.

被引：1
|
作者：
Luu, Thehang H. [1 ]
Blanchard, Suzette [1 ]
Yim, John Hosei [1 ]
机构：
[1] City Hope Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps2637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2637
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant phase II trial with carboplatin and eribulin in triple negative breast cancer patients
    Giordano, S. B.
    Jeruss, J. S.
    Bethke, K. P.
    Hansen, N. M.
    Khan, S.
    Von Roenn, J.
    Rosen, S.
    Gradishar, W. L.
    Siziopikou, K. P.
    Meservey, C.
    Kaklamani, V.
    CANCER RESEARCH, 2013, 73
  • [32] Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy
    Shimomura, Akihiko
    Yonemori, Kan
    Yoshida, Masayuki
    Yoshida, Teruhiko
    Yasojima, Hiroyuki
    Masuda, Norikazu
    Aogi, Kenjiro
    Takahashi, Masato
    Naito, Yoichi
    Shimizu, Satoru
    Nakamura, Rikiya
    Hamada, Akinobu
    Michimae, Hirofumi
    Hashimoto, Jun
    Yamamoto, Harukaze
    Kawachi, Asuka
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    TRANSLATIONAL ONCOLOGY, 2019, 12 (10): : 1386 - 1394
  • [33] Metastatic Triple-negative Breast Cancer
    Rakha, E. A.
    Chan, S.
    CLINICAL ONCOLOGY, 2011, 23 (09) : 587 - 600
  • [34] Metastatic Triple-Negative Breast Cancer
    Zhang, Xiaojie
    Yeung, Kay T.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 288 - 297
  • [35] Metastatic Triple-Negative Breast Cancer
    Xiaojie Zhang
    Kay T. Yeung
    Current Breast Cancer Reports, 2023, 15 : 288 - 297
  • [36] Institutional review of African American (AA) patients with metastatic triple-negative breast cancer.
    Vobugari, Nikitha
    Chitalia, Ami
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Immunogenicity of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple negative breast cancer
    Egelston, Colt A.
    Guo, Weihua
    Yost, Susan E.
    Ge, Xuan
    Lee, Jin Sun
    Frankel, Paul H.
    Cui, Yujie
    Ruel, Christopher
    Schmolze, Daniel
    Murga, Mireya
    Tang, Aileen
    Martinez, Norma
    Karimi, Misagh
    Somlo, George
    Lee, Peter
    Waisman, James
    Yuan, Yuan
    CANCER RESEARCH, 2023, 83 (05)
  • [38] How I treat metastatic triple-negative breast cancer
    Caparica, Rafael
    Lambertini, Matteo
    de Azambuja, Evandro
    ESMO OPEN, 2019, 4
  • [39] The effects of SAHA and EGCG on metastatic potential in triple-negative breast cancer.
    Lewis, Kayla Ashlyn
    Tollefsbol, Trygve O.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 91 - 91
  • [40] A Phase Ib Trial of Erlotinib, an EGFR Inhibitor, and Everolimus (RAD001), an mTOR Inhibitor, in Patients with Metastatic Breast Cancer.
    Mayer, I. A.
    Means-Powell, J.
    Shyr, Y.
    Arteaga, C. L.
    CANCER RESEARCH, 2009, 69 (24) : 677S - 677S
12345